NTAGI panel recommends Sputnik V first dose as precautionary dose
Currently, there is no policy decision on providing a precaution dose to those inoculated with the Russian vaccine.;
Advertisement
New Delhi: The first dose of Sputnik V vaccine can be administered as the precaution dose to all those vaccinated with the Russian COVID-19 jab, an NTAGI panel has recommended, official sources told PTI on Saturday.
The two doses of Sputnik V vaccine have separate compositions.
Currently, there is no policy decision on providing a precaution dose to those inoculated with the Russian vaccine.
The CoWIN portal does not show the option of precaution dose for Sputnik V.
Many Sputnik V recipients who had taken their second dose way back in July last year are unable to get the booster shot.
The two doses of Sputnik V are administered at a gap of 21-30 days.
The first dose of the vaccine contains a recombinant adenovirus type 26 (rAd26-S) and the second dose a recombinant adenovirus 5 (rAd5-S), an official explained.
"The NTAGI's Standing Technical Sub-Committee (STSC) which held its meeting on Friday discussed the issue and recommended that Sputnik Light which has the same component of Sputnik V's first dose will be given as the precaution dose," a official source told PTI.
The National Technical Advisory Group on Immunisation (NTAGI) is an advisory committee comprising multidisciplinary experts responsible for providing information and recommendations to government for making evidence-based decisions regarding vaccine and immunisation policy.
The Union Health Ministry is learnt to have received several representations over the precaution dose of Sputnik V.
According to sources, more than six lakh people have received the Russian vaccine.
The Sputnik V vaccine is based on a proven well-studied human adenovirus vector platform; these vectors cause the common cold and have plagued humanity for millennia. A storage temperature of +2…+8 °C allows the vaccine to be stored in a regular refrigerator without the need to invest in additional cold chain infrastructure. Sputnik V is effective against new strains of coronavirus, according to a study by the Gamaleya Research Institute for Epidemiology and Microbiology published in the leading international magazine Vaccines.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.